These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9387952)

  • 21. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvements in exercise capacity and dyspnoea by inhaled anticholinergic drug in elderly patients with chronic obstructive pulmonary disease.
    Teramoto S; Fukuchi Y
    Age Ageing; 1995 Jul; 24(4):278-82. PubMed ID: 7484482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.
    Pudi KK; Barnes CN; Moran EJ; Haumann B; Kerwin E
    Respir Res; 2017 Nov; 18(1):182. PubMed ID: 29096627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial.
    Abdallah SJ; Wilkinson-Maitland C; Saad N; Li PZ; Smith BM; Bourbeau J; Jensen D
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
    Light RW; Muro JR; Sato RI; Stansbury DW; Fischer CE; Brown SE
    Am Rev Respir Dis; 1989 Jan; 139(1):126-33. PubMed ID: 2492170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebulized opioids for the palliation of dyspnea in terminally ill patients.
    Afolabi TM; Nahata MC; Pai V
    Am J Health Syst Pharm; 2017 Jul; 74(14):1053-1061. PubMed ID: 28687551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease.
    Teramoto S; Fukuchi Y; Orimo H
    Chest; 1993 Jun; 103(6):1774-82. PubMed ID: 8404100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
    Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
    Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nebulized morphine for intractable cough in advanced cancer: two case reports.
    An HJ; Kim IK; Lee JE; Kang YJ; Kim CH; Kim HK
    J Palliat Med; 2015 Mar; 18(3):278-81. PubMed ID: 25679915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of formoterol inhalation on endurance performance in hypobaric conditions.
    Riiser A; Tjørhom A; Carlsen KH
    Med Sci Sports Exerc; 2006 Dec; 38(12):2132-7. PubMed ID: 17146320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does nebulized fentanyl relieve dyspnea during exercise in healthy man?
    Kotrach HG; Bourbeau J; Jensen D
    J Appl Physiol (1985); 2015 Jun; 118(11):1406-14. PubMed ID: 26031762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic efficacy of inhaled morphine in patients after bunionectomy surgery.
    Thipphawong JB; Babul N; Morishige RJ; Findlay HK; Reber KR; Millward GJ; Otulana BA
    Anesthesiology; 2003 Sep; 99(3):693-700; discussion 6A. PubMed ID: 12960555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebulized morphine for the relief of dyspnea.
    Mabe SR; Connelly JF
    Am J Health Syst Pharm; 1995 Jan; 52(2):146-8. PubMed ID: 12879541
    [No Abstract]   [Full Text] [Related]  

  • 35. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1999 Aug; 160(2):542-9. PubMed ID: 10430726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
    Quinn D; Barnes CN; Yates W; Bourdet DL; Moran EJ; Potgieter P; Nicholls A; Haumann B; Singh D
    Pulm Pharmacol Ther; 2018 Feb; 48():71-79. PubMed ID: 28987804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of dextromethorphan on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease (COPD).
    Giron AE; Stansbury DW; Fischer CE; Light RW
    Eur Respir J; 1991 May; 4(5):532-5. PubMed ID: 1936224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease.
    Revill SM; Morgan MD; Singh SJ; Williams J; Hardman AE
    Thorax; 1999 Mar; 54(3):213-22. PubMed ID: 10325896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.